Rationale and design of a prospective, multicenter, cross-sectional study of appropriateness evaluation of the prescription of non-vitamin K antagonist oral anticoagulants for Chinese atrial fibrillation patients (Chi-NOACs-AF trial)

被引:4
作者
Ding, Zheng [1 ]
Zhang, Chi [2 ]
Qian, Yi-Yi [3 ]
Wang, Na [4 ]
Gu, Zhi-Chun [2 ]
Xu, Hang [5 ]
Zheng, Ying-Li [1 ]
机构
[1] Chinese Acad Med Sci, Fuwai Hosp, Dept Pharm, 167 Beilishi Rd, Beijing 100037, Peoples R China
[2] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Pharm, 160 Pujian Rd, Shanghai 200127, Peoples R China
[3] Fuwai Yunnan Cardiovasc Hosp, Dept Pharm, Kunming, Yunnan, Peoples R China
[4] Chongqing Med Univ, Dept Pharm, Affiliated Hosp 2, Chongqing, Peoples R China
[5] Nanjing Univ, Dept Pharm, Affiliated Hosp, Med Sch,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Peoples R China
关键词
Atrial fibrillation (AF); direct oral anticoagulants; prescription; off-label; pharmacist; rivaroxaban; dabigatran; edoxaban; risk factors; PRESCRIBING PATTERNS; ASIAN PATIENTS; RISK-FACTORS; WARFARIN; RIVAROXABAN; DABIGATRAN; SAFETY; STROKE;
D O I
10.21037/atm-20-6893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-vitamin K antagonist oral anticoagulants (NOACs) are alternative to vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation (AF). Along with their widespread clinical use in China, the off-label use of NOACs is commonly seen in real-world practice, which could result in adverse drug events and poor clinical outcomes. However, guideline adherence and label adherence for NOAC prescriptions have not been well evaluated in a real-world setting in China. Methods: Between January 2021 and June 2021, a total of 1,750 outpatients or inpatients with AF will be consecutively enrolled at 26 canters in China. Data on patient demographics, clinical characteristics, treatment strategies, and prescribing information related to anticoagulation therapy for patients with AF will be collected. Clinical pharmacists will evaluate the rationality of the anticoagulation regimens and NOAC prescriptions based on the guideline recommendations and drug labels that are approved by the National Medical Products Administration. The primary outcomes will be the prevalence of irrational anticoagulation strategies and the inappropriate NOAC prescriptions, as well as potential risk factors associated with inappropriate prescriptions in patients with AF. Discussion: This study will be the first national, multicenter, prospective study performed by pharmacists to explore real-world data on the appropriateness of NOAC prescription in Chinese patients with AF.
引用
收藏
页数:10
相关论文
共 38 条
[11]  
Ertas F, 2009, TURK KARDIYOL DERN A, V37, P161
[12]   Edoxaban versus Warfarin in Patients with Atrial Fibrillation [J].
Giugliano, Robert P. ;
Ruff, Christian T. ;
Braunwald, Eugene ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Halperin, Jonathan L. ;
Waldo, Albert L. ;
Ezekowitz, Michael D. ;
Weitz, Jeffrey I. ;
Spinar, Jindrich ;
Ruzyllo, Witold ;
Ruda, Mikhail ;
Koretsune, Yukihiro ;
Betcher, Joshua ;
Shi, Minggao ;
Grip, Laura T. ;
Patel, Shirali P. ;
Patel, Indravadan ;
Hanyok, James J. ;
Mercuri, Michele ;
Vogelmann, O. ;
Gonzalez, C. ;
Ahuad Guerrero, R. ;
Rodriguez, M. ;
Albisu, J. ;
Rosales, E. ;
Allall, O. ;
Reguero, M. ;
Alvarez, C. ;
Garcia, M. ;
Ameriso, S. ;
Ameriso, P. ;
Amuchastegui, M. ;
Caceres, M. ;
Beloscar, J. ;
Petrucci, J. ;
Berli, M. ;
Budassi, N. ;
Valle, M. ;
Bustamante Labarta, G. ;
Saravia, M. ;
Caccavo, A. ;
Fracaro, V. ;
Cartasegna, L. ;
Novas, V. ;
Caruso, O. ;
Saa Zarandon, R. ;
Colombo, H. ;
Morandini, M. ;
Cuello, J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) :2093-2104
[13]   Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].
Granger, Christopher B. ;
Alexander, John H. ;
McMurray, John J. V. ;
Lopes, Renato D. ;
Hylek, Elaine M. ;
Hanna, Michael ;
Al-Khalidi, Hussein R. ;
Ansell, Jack ;
Atar, Dan ;
Avezum, Alvaro ;
Cecilia Bahit, M. ;
Diaz, Rafael ;
Easton, J. Donald ;
Ezekowitz, Justin A. ;
Flaker, Greg ;
Garcia, David ;
Geraldes, Margarida ;
Gersh, Bernard J. ;
Golitsyn, Sergey ;
Goto, Shinya ;
Hermosillo, Antonio G. ;
Hohnloser, Stefan H. ;
Horowitz, John ;
Mohan, Puneet ;
Jansky, Petr ;
Lewis, Basil S. ;
Luis Lopez-Sendon, Jose ;
Pais, Prem ;
Parkhomenko, Alexander ;
Verheugt, Freek W. A. ;
Zhu, Jun ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992
[14]   Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis [J].
Gu, Zhi-Chun ;
Wei, An-Hua ;
Zhang, Chi ;
Wang, Xin-Hua ;
Zhang, Le ;
Shen, Long ;
Li, Zheng ;
Pan, Mang-Mang ;
Liu, Xiao-Yan ;
Pu, Jun ;
Lin, Hou-Wen .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (04) :792-+
[15]   Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study [J].
Guo, Yutao ;
Wang, Yutang ;
Li, Xiaoying ;
Shan, Zaoliang ;
Shi, Xiangmin ;
Xi, Guorong ;
Lip, Gregory Y. H. .
BMJ OPEN, 2018, 8 (05)
[16]   Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study [J].
Hori, Masatsugu ;
Matsumoto, Masayasu ;
Tanahashi, Norio ;
Momomura, Shin-ichi ;
Uchiyama, Shinichiro ;
Goto, Shinya ;
Izumi, Tohru ;
Koretsune, Yukihiro ;
Kajikawa, Mariko ;
Kato, Masaharu ;
Ueda, Hitoshi ;
Iwamoto, Kazuya ;
Tajiri, Masahiro .
CIRCULATION JOURNAL, 2012, 76 (09) :2104-2111
[17]   Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants [J].
Howard, Molly ;
Lipshutz, Andrew ;
Roess, Breanne ;
Hawes, Emily ;
Deyo, Zachariah ;
Burkhart, Jena Ivey ;
Moll, Stephan ;
Shilliday, Betsy Bryant .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (02) :149-156
[18]   Appropriateness of Prescribing Dabigatran Etexilate and Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation: A Prospective Study [J].
Larock, Anne-Sophie ;
Mullier, Francois ;
Sennesael, Anne-Laure ;
Douxfils, Jonathan ;
Devalet, Berangere ;
Chatelain, Christian ;
Dogne, Jean-Michel ;
Spinewine, Anne .
ANNALS OF PHARMACOTHERAPY, 2014, 48 (10) :1258-1268
[19]   Characteristics of hospitalized patients with atrial fibrillation in Taiwan: A nationwide observation [J].
Lee, Cheng-Han ;
Liu, Ping-Yen ;
Tsai, Liang-Miin ;
Tsai, Wei-Chuan ;
Ho, Ming-Tsung ;
Chen, Jyh-Hong ;
Lin, Li-Jen .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (09) :819.e1-819.e7
[20]   Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation [J].
Lee, So-Ryoung ;
Lee, Young Soo ;
Park, Ji-Suck ;
Cha, Myung-Jin ;
Kim, Tae-Hoon ;
Park, Junbeom ;
Park, Jin-Kyu ;
Lee, Jung-Myung ;
Kang, Ki-Woon ;
Shim, Jaemin ;
Uhm, Jae-Sun ;
Kim, Jun ;
Kim, Changsoo ;
Kim, Jin-Bae ;
Park, Hyung Wook ;
Joung, Boyoung ;
Choi, Eue-Keun .
YONSEI MEDICAL JOURNAL, 2019, 60 (03) :277-284